Susquehanna International Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,500
Closed -$331K 32
2020
Q4
$331K Sell
3,500
-10,000
-74% -$874K 0.24% 35
2020
Q3
$1.17M Buy
13,500
+10,000
+286% +$866K 0.62% 32
2020
Q2
$306K Hold
3,500
0.13% 63
2020
Q1
$289K Buy
+3,500
New +$312K 0.12% 71
2019
Q2
Sell
-70,978
Closed -$6.12M 95
2019
Q1
$6.12M Buy
+70,978
New +$5.7M 1.5% 22

Other funds holding NVS

Susquehanna International Securities's NVS Position: Q3 2024 in Review

Susquehanna International Securities opened a new position in Novartis (NVS) in Q3 2024: 25,400 shares worth $2.92M. The stake represents 0.69% of the portfolio and ranks #15 among its holdings. This is a return to the name: Susquehanna International Securities previously reported a position in NVS as recently as Q4 2023.

Susquehanna International Securities first reported a position in NVS in Q4 2018 and has held it in 7 quarters since. The position peaked at $11.2M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Susquehanna International Securities held 25,400 shares of Novartis worth $2.92M as of Q3 2024.
  • Novartis was a new Susquehanna International Securities position in Q3 2024.
  • Novartis made up 0.69% of Susquehanna International Securities's portfolio in Q3 2024, its #15 holding.
  • Susquehanna International Securities first reported a position in Novartis in Q4 2018 and has held it in 7 quarters since.
  • Susquehanna International Securities's Novartis position peaked at $11.2M in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Susquehanna International Securities's 13F filing for Q3 2024, filed 14 Nov 2024.